Resistance plasmids vs. chromosomal resistance

Learn how resistance plasmids differ from chromosomal resistance and what their detection may indicate—and what a gene result alone cannot tell you.

Close-up of laboratory equipment against a blurred background

Plasmids are DNA molecules that can carry antibiotic resistance genes; chromosomal resistance is associated with changes in the bacterial chromosome. Detecting a gene alone does not confirm that it is expressed or determine which treatment is appropriate.

This information is general and does not replace an assessment by a healthcare professional.

In summary:

  • Plasmids are DNA molecules separate from the chromosome and can carry resistance genes, but their presence alone does not confirm a resistant phenotype.
  • Chromosomal resistance is associated with changes in the bacterial chromosome; some resistance genes can also be found on mobile genetic elements.
  • Some plasmids can facilitate the horizontal transfer of genes between bacteria, but whether this occurs depends on the plasmid, the bacteria involved and the conditions.
  • Detecting a resistance gene in a sample is not enough to always identify which microorganism carries it, determine whether it is expressed or decide on a treatment.

Interpreting the finding requires considering the sample and the clinical situation. Molecular detection provides different information from phenotypic susceptibility tests and requires professional assessment.

How do resistance plasmids differ from chromosomal resistance?

They differ in where the genetic change is located: plasmids are DNA molecules separate from the bacterial chromosome and can carry resistance genes, while chromosomal resistance is associated with changes in the DNA of the chromosome itself. Neither location alone confirms how the bacterium will respond to an antibiotic.

A gene is a DNA sequence that contains genetic information. Detecting a sequence associated with resistance does not, by itself, show that the sequence is active or that the bacterium is resistant to the drug: a molecular finding is not the same as observing how the bacterium behaves when exposed to the antibiotic.

The two categories are not necessarily mutually exclusive: a bacterium can have genetic determinants on both its chromosome and plasmids. For more on identifying a microorganism in an infection, see the guide to sepsis and pathogens.

Can plasmids transfer resistance between bacteria?

Yes. Some plasmids can facilitate the transfer of resistance genes from one bacterium to another through horizontal gene transfer, the movement of genetic material between organisms without direct reproduction. Whether this occurs in a particular situation depends on the characteristics of the plasmid, the bacteria involved and the environment.

During conjugation, one bacterium transfers genetic material to another through cell-to-cell contact; some plasmids can be involved in this process. Other mechanisms of horizontal gene transfer include transformation, which involves taking up free DNA, and transduction, which involves bacterial viruses. These mechanisms do not mean that all plasmids are transferred or that exchange necessarily occurs during a particular infection.

Therefore, the biological possibility of transfer does not allow its likelihood to be calculated for a specific patient or environment. For enquiries about urgent bloodstream infections, the AMC Critical en sangre page provides information about the service and its relationship to antimicrobial resistance.

What limits the detection of resistance genes in a sample?

Detecting a sequence associated with resistance in a sample does not always make it possible to identify which microorganism carries it or determine whether the gene is active and has a clinical effect. Interpretation depends on the sample type, the method used, and the microbiological and clinical context.

Molecular detection identifies genetic material, but it is not the same as observing how a bacterium responds to an antibiotic. Also, if the sequence cannot be clearly linked to a microorganism, its relevance to the infection may remain uncertain. The result should therefore be considered alongside the other findings and the clinical question.

In metagenomics, the ability to assign a sequence depends on the specific analysis. The information available does not allow us to specify the scope of each test here. The blood metagenomic analysis page provides information about the service. To assess a result, the healthcare professional should consider which sample was analysed and which method was used.

How should a resistance gene be interpreted in a metagenomic report?

A resistance gene detected in a metagenomic report should be interpreted alongside the sample type, the microorganisms identified and the clinical situation. On its own, it does not confirm that the microorganism expresses resistance or constitute a treatment recommendation.

Molecular detection identifies genetic material associated with resistance. It is not equivalent to a phenotypic antimicrobial susceptibility test, which assesses how the microorganism responds to antimicrobials under the conditions of the test. Each provides different information, and the usefulness of each result depends on the clinical question and microbiological context.

It is therefore important to assess whether the microorganism detected is relevant to the infection being investigated and to review the result with a healthcare professional. Healthcare professionals can visit the professionals’ access page to request analyses. Treatment choices are based on clinical assessment; they should not be inferred from an isolated gene.

What tests can help guide the assessment of an antimicrobial-resistant infection?

The choice of tests to assess an antimicrobial-resistant infection depends on the sample and the clinical question. Molecular and phenotypic tests provide different information and should be interpreted by a healthcare professional in the context of the patient’s situation before clinical decisions are made.

In general, a molecular test looks for genetic material associated with microorganisms or resistance mechanisms. Detecting it does not, by itself, confirm that the microorganism is causing the infection or automatically indicate which treatment would be appropriate.

Phenotypic tests, such as antimicrobial susceptibility tests, provide information about how the microorganism responds to the antimicrobials tested. They are not interchangeable with molecular detection: each result answers a different question and must be assessed in relation to the sample and the clinical situation.

Test selection and interpretation are the responsibility of a healthcare professional. To find out which tests Xenogene offers, see the catalogue of available tests.

Frequently asked questions

Can plasmid-mediated and chromosomal resistance coexist?

Yes. Resistance associated with plasmids and resistance linked to chromosomal changes are not necessarily mutually exclusive: a bacterium can have genetic determinants of both types. Identifying where a gene is located helps interpret the result, but is not enough on its own to describe the bacterium’s full resistance profile.

Do all plasmids contain resistance genes?

No. A plasmid can carry resistance genes, but its presence does not necessarily mean that it does. The term “plasmid” describes a DNA molecule separate from the chromosome; it does not indicate which genes it carries or what effects they might have. Interpretation depends on the sequence detected and the context of the analysis.

Does detecting a plasmid prove that resistance was transmitted between people?

No. Detecting a resistance-associated sequence in a sample does not prove direct transmission between people or, by itself, establish how the sequence got there. Transfer between bacteria and transmission between people are distinct issues; identifying a specific route requires additional information, not just molecular detection.

Does the presence of a plasmid confirm an active infection?

Not on its own. A genetic finding in a sample does not, by itself, establish whether there is an active infection or what its clinical relevance is. A healthcare professional should assess the result alongside the sample type, microbiological findings and the person’s clinical situation.

See information about AMC Critical to assess whether this analysis is relevant to the clinical question.

Other related tests

  • Microbiota Esencial

    Análisis metagenómico clínico dirigido a la evaluación cuantitativa y cualitativa de los 150 microorganismos intestinales más relevantes para la salud humana.

  • Microbiota Intestinal

    Análisis metagenómico completo de la microbiota intestinal con tecnología Nanopore NGS de máxima profundidad para detectar disbiosis y proporcionar recomendaciones personalizadas.

  • Test de Microbiota Bucal

    Estudio completo de la microbiota oral, analizando todos los microorganismos que habitan en los distintos nichos de la cavidad oral: bacterias G+ y G-, arqueas, hongos y virus.

See the full catalogue

#metagenomica#microbiota#ngs